Skip to main navigation Skip to search Skip to main content

Clinical epidemiology of Buruli ulcer disease in Ghana, 2006–2024

  • Yaw A. Amoako
  • , Bernadette Agbavor
  • , Michael Frimpong
  • , Abigail Agbanyo
  • , Aloysius D D. Loglo
  • , Michael N. Oppong
  • , Philemon B. Antwi
  • , Adwoa A. Adu-Gyamfi
  • , Ruth D. Tuwor
  • , Michael N. Appau
  • , Dzifa Ahiatrogah
  • , Kabiru M. Abass
  • , Elizabeth Ofori
  • , George Amofa
  • , Nana K. Kotey
  • , Thorsten Thye
  • , Denise Dekker
  • , Kingsley Asiedu
  • , Mark Wansbrough-Jones
  • , Ymkje Stienstra
  • Richard O. Phillips
  • Kwame Nkrumah University of Science and Technology
  • Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR)
  • Agogo Presby Hospital
  • Tepa Government Hospital
  • Dunkwa Government Hospital
  • Ghana Health Service
  • Bernhard Nocht Institute for Tropical Medicine
  • World Health Organization
  • City St George's, University of London
  • University Medical Centre Groningen
  • University of Groningen

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Background: Buruli ulcer, a neglected tropical disease, is common in West Africa and imposes a significant burden on health systems. Examining epidemiological data is important to guide health systems planning to facilitate control activities in endemic countries. 

Objectives: We aimed to provide a comprehensive description of the clinical epidemiology of a large cohort of polymerase chain reaction-confirmed cases of Buruli ulcer in districts in the middle belt of Ghana over an 18-year period. Methods: We retrospectively analysed demographic and clinical data for affected individuals. Data were collected using World Health Organization standard case-based forms and managed in Microsoft Excel. Descriptive analysis was performed using SPSS and Stata statistical software. 

Results: In total, 956 individuals with a median (interquartile range) age of 18 (10–35) years were included; 40% (385/956) of patients with Buruli ulcer were under 15 years. Clinical lesions included ulcers (61.5%), nodules (15.6%), plaques (14%) and osteomyelitis (1.4%). Regarding lesion severity, 38.6% were category I, 32.3% category II and 22.6% category III. Most lesions (51.7%) were located on the lower limbs. There was notable variability in the number of recorded cases across the years, with 2014 witnessing the highest and 2010 the lowest numbers. The Ahafo Ano North district reported the highest number of cases. 

Conclusions: Despite a general decline in case numbers, Ghana continues to be an endemic area for Buruli ulcer. Our findings support the need for policies emphasizing active surveillance for early case detection using integrated approaches. Further investigation into the changing epidemiology of Buruli ulcer is warranted.

Original languageEnglish
Pages (from-to)831-839
Number of pages9
JournalClinical and Experimental Dermatology
Volume51
Issue number5
Early online date26 Jul 2025
DOIs
Publication statusPublished - 1 May 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Clinical epidemiology of Buruli ulcer disease in Ghana, 2006–2024'. Together they form a unique fingerprint.

Cite this